RE/MAX Holdings, Inc.
RMAXRE/MAX Holdings, Inc.'s balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup.
Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding.
The price is topping out (16 weeks in) while the P/E sits at the 70th percentile of its own 4-year range. But the balance sheet is under water: net worth is negative, so shareholders sit behind everyone the company owes. What settles it: whether the business can earn its way back to positive equity before dilution or restructuring gets there first.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
RE/MAX Holdings, Inc. trades at $9.7, losing momentum at the top and 16 weeks into that stage. That is +18.6% against its own 200-day average. It sits at 74% of a 52-week range of $6 to $11. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (2 weeks and counting).
Today the stock is losing momentum at the top — week 16 of stage 3. At $9.7 it trades +18.6% versus its 200-day average and sits at 74% of its 52-week range ($6–$11).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved −76% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (2 weeks and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
RE/MAX Holdings, Inc. trades at 885.9× P/E, at the pricey end of its own range (70th percentile). Its long-run median P/E is 36.5×, measured across 3.8 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 885.9× is at the pricey end of its own range (70th percentile), against a long-run median of 36.5× measured over 3.8 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +8.1% against a +28.8% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 3y, of the −20.7%/yr price move, ~+0.0%/yr came from earnings growth and ~−20.7 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
RE/MAX Holdings, Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 12 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
The return-on-capital curve is not shown — net worth is negative, so a return on capital is not a meaningful number in any basis. This is a distressed balance sheet, and the stage is read from the growth curves alone.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −6.5% | −6.1% | — | — |
| Profit | +0.0% | +0.0% | — | — |
| EPS | +8.1% | +7.7% | — | — |
| Stock price | +28.8% | −20.7% | −22.4% | −13.9% |
4-Factor Sector Score
38.7/100 — rank 17 of 27 in Real Estate Services · 74% evidence confidence
RE/MAX Holdings, Inc. scores 38.7 out of 100 against the 27 companies it is compared with in Real Estate Services, ranking 17. Price leads the evidence: RS versus the benchmark is 4.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
The four contributions add to the total exactly: 9.2 + 7.5 + 8.7 + 13.3 = 38.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
RE/MAX Holdings, Inc. reported $0.1 B of revenue in the Mar 26 quarter, +0.0% year on year. Over 4 years it has compounded at −3.2% a year. The last full year, FY25, came in at $0.3 B. The last four reported quarters add to $0.3 B.
FY25 revenue came in at $0.3 B (−6.5% on the year), capping 4 years at −3.2% compound. The latest quarter (Mar 26) printed $0.1 B, +0.0% year on year.
Pace check: the last four quarters averaged −6.3% growth against the decade's −3.2% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −6.7% over the last 4 quarters against −6.5%/yr over the last 8 — stabilising.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
RE/MAX Holdings, Inc.'s operating margin is −14.3% in the Mar 26 quarter, −28.6 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged −3.0% to 17.2%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is −14.3%, −28.6 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −3.0%–17.2%, and FY25's 17.2% is the top of that band — a record year.
🚨 Why the margin moved: operating margin went −28.6 pp year on year while gross margin went +0.0 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
RE/MAX Holdings, Inc. posted a net loss of $0.02 B in the Mar 26 quarter. Full-year FY25 profit was $0.0 B. That loss is 28.6% of the quarter's revenue. The same quarter a year earlier earned $0.0 B. 4 of the last 12 reported quarters were loss-making.
Mar 26 profit was $−0.0 B, null year on year. On the full year, FY25 printed $0.0 B (+0.0%).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 567% of RE/MAX Holdings, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.0 B of operating cash against $0.0 B of profit. After $0.0 B of capital spending, $0.0 B was left as free cash.
FY25: operating cash of $0.0 B against reported profit of $0.0 B, leaving free cash of $0.0 B after $0.0 B of capital spending. Across the last 3 fiscal years the conversion rate is 567% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
RE/MAX Holdings, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
RE/MAX Holdings, Inc. earns a ROE of −33% in FY25. Return on invested capital clears the cost of that capital by −5.1 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 3.4% net margin on 0.50× asset turns.
FY25 ROE is −33%.
🚨 Why the return is what it is — the wiring (FY25): 3.4% net margin × 0.50× asset turns × −19.33× balance-sheet leverage ≈ −32.9% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 1.4% − 6.5% = a −5.1 pp spread. The 6.5% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
RE/MAX Holdings, Inc. has 2 quarters of declared dividends on file — too few for a trailing-twelve-month figure. The most recent declaration was $0.23 for Sep 23.
RE/MAX Holdings, Inc. has declared a dividend in 2 of the last 12 reported quarters, most recently $0.23 for Sep 23. That is fewer than four quarters, so no trailing-twelve-month total is shown rather than one built from a partial year.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
RE/MAX Holdings, Inc.'s net worth is negative — it owes more than it owns — so a debt-to-equity ratio is not meaningful here. On the annual view that ratio went from 7.14 in FY21 to −15.33 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.
Mar 26: total debt of $0.5 B against shareholder equity of $−0.0 B — a debt-to-equity of −11.50. On the annual view, debt-to-equity went from 7.14 (FY21) to −15.33 (FY25). The returns on this page are earned, not borrowed.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
7.0% of RE/MAX Holdings, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 3.6 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 7.0% of the float is sold short, and at typical trading volumes it would take about 3.6 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
RE/MAX Holdings, Inc.: the Z-score reads 0.75. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of 0.75 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads 0.75.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Jones Lang LaSalle IncorporatedJLL | 64.8/100Thin evidence · provisional58% evidence | TURNING | 21.3/35 Revenue — · PAT — · OPM change 1.1 pp 45% evidence | 14.8/25 ROCE 2.8% · OPM 3.2% 76% evidence | 10.9/20 P/E 14.9× · PEG — 15% evidence | 17.8/20 RS sector 17.1% · RS bench 4.1% · 1Y 32.2%2 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 14.8 + 10.9 + 17.8 = 64.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2The RMR Group Inc.RMR | 60.7/100Mixed-positive evidence75% evidence | ASLEEP | 16.0/35 Revenue -20.4% · PAT 0% · OPM change 0.3 pp 83% evidence | 14.3/25 ROCE 1.2% · OPM 4.8% 76% evidence | 16.2/20 P/E 12.8× · PEG 0.46 65% evidence | 14.2/20 RS sector 11.1% · RS bench -0.5% · 1Y 18.4%10 of 12 weeks ahead 70% evidence |
| Exact sum: 16 + 14.3 + 16.2 + 14.2 = 60.7 · Decision use: Price leads the evidence: RS versus the benchmark is -0.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 3CBRE Group, Inc.CBRE | 56.6/100Thin evidence · provisional58% evidence | BASING | 19.8/35 Revenue — · PAT — · OPM change 1.8 pp 45% evidence | 15.4/25 ROCE 2% · OPM 4.9% 76% evidence | 10.2/20 P/E 30.9× · PEG — 15% evidence | 11.2/20 RS sector 1.8% · RS bench -10% · 1Y -2.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 15.4 + 10.2 + 11.2 = 56.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Star HoldingsSTHO | 53.7/100Thin evidence · provisional58% evidence | TURNING | 21.3/35 Revenue 11.5% · PAT — · OPM change 21.4 pp 62% evidence | 7.1/25 ROCE -1.2% · OPM -29.6% 76% evidence | 11.5/20 P/E 2.3× · PEG — 15% evidence | 13.8/20 RS sector 10.9% · RS bench -1% · 1Y 26.6%4 of 12 weeks ahead 70% evidence |
| Exact sum: 21.3 + 7.1 + 11.5 + 13.8 = 53.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5FirstService CorporationFSV | 53.6/100Thin evidence · provisional58% evidence | TURNING | 20.0/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence | 15.7/25 ROCE 2.9% · OPM 3.5% 76% evidence | 9.7/20 P/E 40.3× · PEG — 15% evidence | 8.2/20 RS sector -8.7% · RS bench -19.5% · 1Y -28.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 15.7 + 9.7 + 8.2 = 53.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Marcus & Millichap, Inc.MMI | 53.0/100Thin evidence · provisional58% evidence | ASLEEP | 22.3/35 Revenue 9.7% · PAT — · OPM change 8.8 pp 62% evidence | 8.4/25 ROCE -0.8% · OPM -3.4% 76% evidence | 9.4/20 P/E 47.7× · PEG — 15% evidence | 12.9/20 RS sector 8.3% · RS bench -3.7% · 1Y 6.4%6 of 12 weeks ahead 70% evidence |
| Exact sum: 22.3 + 8.4 + 9.4 + 12.9 = 53 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7CoStar Group, Inc.CSGP | 50.1/100Thin evidence · provisional58% evidence | BASING | 22.9/35 Revenue — · PAT — · OPM change 6.2 pp 45% evidence | 12.3/25 ROCE 0.8% · OPM 0.3% 76% evidence | 9.3/20 P/E 149.1× · PEG — 15% evidence | 5.6/20 RS sector -44.2% · RS bench -51.8% · 1Y -68.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.9 + 12.3 + 9.3 + 5.6 = 50.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8Newmark Group, Inc.NMRK | 49.6/100Thin evidence · provisional58% evidence | BASING | 20.6/35 Revenue — · PAT — · OPM change 5.8 pp 45% evidence | 13.3/25 ROCE 1.3% · OPM 3.2% 76% evidence | 10.5/20 P/E 18.7× · PEG — 15% evidence | 5.2/20 RS sector -2.6% · RS bench -13.9% · 1Y -2.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.6 + 13.3 + 10.5 + 5.2 = 49.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9IHS Holding LimitedIHS | 48.9/100Mixed-negative evidence64% evidence | ASLEEP | 12.2/35 Revenue 3.7% · PAT — · OPM change -15.5 pp 62% evidence | 15.2/25 ROCE 3.2% · OPM 26.8% 76% evidence | 10.8/20 P/E 15.5× · PEG — 15% evidence | 10.7/20 RS sector 7.5% · RS bench -3.8% · 1Y 23.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.2 + 15.2 + 10.8 + 10.7 = 48.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Transcontinental Realty Investors, Inc.TCI | 48.5/100Mixed-negative evidence75% evidence | BREAKING OUT | 14.8/35 Revenue 2.1% · PAT 0% · OPM change -10.6 pp 83% evidence | 9.8/25 ROCE -0.2% · OPM -15.9% 76% evidence | 15.0/20 P/E 32× · PEG 0.54 65% evidence | 8.9/20 RS sector -0.9% · RS bench -12.5% · 1Y 4.4%6 of 12 weeks ahead 70% evidence |
| Exact sum: 14.8 + 9.8 + 15 + 8.9 = 48.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 11Compass, Inc.COMP | 47.7/100Mixed-negative evidence64% evidence | BREAKING OUT | 14.9/35 Revenue 40.1% · PAT — · OPM change -9 pp 62% evidence | 4.2/25 ROCE -8.9% · OPM -13% 76% evidence | 9.0/20 P/E 365.5× · PEG — 15% evidence | 19.6/20 RS sector 27% · RS bench 12.7% · 1Y 47.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 14.9 + 4.2 + 9 + 19.6 = 47.7 · Decision use: Price leads the evidence: RS versus the benchmark is 12.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 12Colliers International Group Inc.CIGI | 47.3/100Thin evidence · provisional58% evidence | BASING | 17.3/35 Revenue — · PAT — · OPM change -0.1 pp 45% evidence | 14.1/25 ROCE 1.8% · OPM 2.7% 76% evidence | 9.6/20 P/E 44.6× · PEG — 15% evidence | 6.3/20 RS sector -21.1% · RS bench -30.9% · 1Y -37%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.3 + 14.1 + 9.6 + 6.3 = 47.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Cushman & Wakefield LimitedCWK | 46.6/100Mixed-negative evidence71% evidence | BASING | 18.3/35 Revenue 10.4% · PAT -53.8% · OPM change 0.3 pp 83% evidence | 11.8/25 ROCE 1.1% · OPM 2.3% 76% evidence | 9.9/20 P/E 38.3× · PEG — 15% evidence | 6.6/20 RS sector -2.5% · RS bench -13.9% · 1Y 2.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 11.8 + 9.9 + 6.6 = 46.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14American Realty Investors, Inc.ARL | 43.1/100Thin evidence · provisional58% evidence | TURNING | 15.0/35 Revenue 4.2% · PAT — · OPM change -11 pp 62% evidence | 9.1/25 ROCE -0.2% · OPM -17.8% 76% evidence | 10.3/20 P/E 20.3× · PEG — 15% evidence | 8.7/20 RS sector -1.2% · RS bench -12.2% · 1Y 20%5 of 12 weeks ahead 70% evidence |
| Exact sum: 15 + 9.1 + 10.3 + 8.7 = 43.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15The Real Brokerage Inc.REAX | 42.8/100Thin evidence · provisional55% evidence | BASING | 23.9/35 Revenue 46.8% · PAT — · OPM change 0.8 pp 62% evidence | 5.2/25 ROCE -7% · OPM -0.7% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.7/20 RS sector -42.9% · RS bench -50.6% · 1Y -55.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 23.9 + 5.2 + 10 + 3.7 = 42.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Seaport Entertainment Group Inc.SEG | 41.4/100Thin evidence · provisional55% evidence | BREAKING OUT | 12.3/35 Revenue 13.4% · PAT — · OPM change -130.3 pp 62% evidence | 3.8/25 ROCE -7% · OPM -333.8% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 15.3/20 RS sector 15.9% · RS bench 3.3% · 1Y 13%8 of 12 weeks ahead 70% evidence |
| Exact sum: 12.3 + 3.8 + 10 + 15.3 = 41.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17RE/MAX Holdings, Inc.this pageRMAX | 38.7/100Mixed-negative evidence74% evidence | ASLEEP | 9.2/35 Revenue -5% · PAT -90% · OPM change -18.3 pp 62% evidence | 7.5/25 ROCE -1.8% · OPM -11.1% 76% evidence | 8.7/20 P/E 576× · PEG 1.66 65% evidence | 13.3/20 RS sector 17% · RS bench 4.2% · 1Y 20.5%10 of 12 weeks ahead 100% evidence |
| Exact sum: 9.2 + 7.5 + 8.7 + 13.3 = 38.7 · Decision use: Price leads the evidence: RS versus the benchmark is 4.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 18FRP Holdings, Inc.FRPH | 38.0/100Mixed-negative evidence65% evidence | TURNING | 11.7/35 Revenue 4.8% · PAT -85.7% · OPM change -17.8 pp 83% evidence | 10.9/25 ROCE 0.1% · OPM 4.8% 76% evidence | 8.7/20 P/E 547× · PEG — 15% evidence | 6.7/20 RS sector -3.7% · RS bench -14.5% · 1Y -13.5%0 of 12 weeks ahead 70% evidence |
| Exact sum: 11.7 + 10.9 + 8.7 + 6.7 = 38 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19AGNT, IncAGNT | 37.9/100Thin evidence · provisional58% evidence | ASLEEP | 18.6/35 Revenue 5.3% · PAT — · OPM change 0.2 pp 62% evidence | 7.5/25 ROCE -3.8% · OPM -0.9% 76% evidence | 8.8/20 P/E 406× · PEG — 15% evidence | 3.0/20 RS sector -46.1% · RS bench -53.2% · 1Y -57.6%0 of 12 weeks ahead 70% evidence |
| Exact sum: 18.6 + 7.5 + 8.8 + 3 = 37.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Maui Land & Pineapple Company, Inc.MLP | 37.4/100Mixed-negative evidence65% evidence | TURNING | 11.4/35 Revenue 20% · PAT -500% · OPM change -28.5 pp 83% evidence | 4.9/25 ROCE -5.5% · OPM -59.2% 76% evidence | 9.1/20 P/E 239.2× · PEG — 15% evidence | 12.0/20 RS sector 6.6% · RS bench -5.2% · 1Y 4.9%4 of 12 weeks ahead 70% evidence |
| Exact sum: 11.4 + 4.9 + 9.1 + 12 = 37.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Douglas Elliman Inc.DOUG | 32.3/100Thin evidence · provisional58% evidence | ASLEEP | 9.7/35 Revenue -5.3% · PAT — · OPM change -6.1 pp 62% evidence | 6.3/25 ROCE -4.8% · OPM -8.2% 76% evidence | 11.1/20 P/E 13.9× · PEG — 15% evidence | 5.2/20 RS sector -20.5% · RS bench -30.3% · 1Y -21.4%1 of 12 weeks ahead 70% evidence |
| Exact sum: 9.7 + 6.3 + 11.1 + 5.2 = 32.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 22Seritage Growth PropertiesSRG | 31.0/100Thin evidence · provisional51% evidence | ASLEEP | 9.2/35 Revenue 0% · PAT — · OPM change -635.5 pp 62% evidence | 7.3/25 ROCE -4.2% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.5/20 RS sector -22.5% · RS bench -32% · 1Y -15%0 of 12 weeks ahead 70% evidence |
| Exact sum: 9.2 + 7.3 + 10 + 4.5 = 31 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Opendoor Technologies Inc.OPEN | 23.0/100Adverse evidence61% evidence | ASLEEP | 7.9/35 Revenue -23.2% · PAT — · OPM change -17.2 pp 62% evidence | 4.0/25 ROCE -7.5% · OPM -22.1% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 1.1/20 RS sector -27.1% · RS bench -36.1% · 1Y 111.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 7.9 + 4 + 10 + 1.1 = 23 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Comstock Holding Companies, Inc.CHCI | 64.1/100Thin evidence · provisional47% evidence | BASING | 23.0/35 Revenue 24.1% · PAT 13.3% · OPM change — 45% evidence | 13.6/25 ROCE — · OPM — 15% evidence | 15.9/20 P/E 11.4× · PEG 0.83 65% evidence | 11.6/20 RS sector 5.6% · RS bench -5.7% · 1Y 11.9%4 of 12 weeks ahead 70% evidence |
| Exact sum: 23 + 13.6 + 15.9 + 11.6 = 64.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25Rafael Holdings, Inc.RFL | 54.8/100Thin evidence · provisional24% evidence | BREAKING OUT | 16.3/35 Revenue — · PAT — · OPM change — 8% evidence | 10.9/25 ROCE — · OPM — 15% evidence | 10.6/20 P/E 18.1× · PEG — 15% evidence | 17.0/20 RS sector 34.8% · RS bench 20.9% · 1Y 23.5%9 of 12 weeks ahead 70% evidence |
| Exact sum: 16.3 + 10.9 + 10.6 + 17 = 54.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26New England Realty Associates Limited PartnershipNEN | 43.7/100Thin evidence · provisional48% evidence | BASING | 11.8/35 Revenue 14.8% · PAT -112.5% · OPM change -23.9 pp 83% evidence | 11.9/25 ROCE 0.4% · OPM 6.2% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y -20.2%0 of 10 weeks ahead 0% evidence |
| Exact sum: 11.8 + 11.9 + 10 + 10 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 27Hotel101 Global Holdings Corp.HBNB | 43.1/100Thin evidence · provisional29% evidence | ASLEEP | 18.3/35 Revenue — · PAT — · OPM change — 9% evidence | 8.9/25 ROCE -1.7% · OPM — 46% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.9/20 RS sector -7.9% · RS bench -17.5% · 1Y 213.7%0 of 12 weeks ahead 70% evidence |
| Exact sum: 18.3 + 8.9 + 10 + 5.9 = 43.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is RE/MAX Holdings, Inc.'s stock price today?
RE/MAX Holdings, Inc. trades at $9.7, +28.8% over the past year. The company is valued at $0.0 B. The stock sits at 74% of its 52-week range of $6–$11, +18.6% versus its 200-day average. On the tape, the price is topping out, 16 weeks in. — as of 5 August 2026.
What were RE/MAX Holdings, Inc.'s latest quarterly results?
RE/MAX Holdings, Inc. reported revenue of $0.1 B and a net loss of $0.0 B for the Mar 26 quarter. Earnings per share were $−0.48. The operating margin was −14.3%, 28.6 pp lower than a year earlier. — as of 5 August 2026.
What is RE/MAX Holdings, Inc.'s revenue?
RE/MAX Holdings, Inc. reported revenue of $0.1 B in the Mar 26 quarter, +0.0% year on year. For the full FY25 fiscal year, revenue was $0.3 B (−6.5%). Over the last 4 years revenue compounded at −3.2% a year. — as of 5 August 2026.
What is RE/MAX Holdings, Inc.'s profit?
RE/MAX Holdings, Inc. earned $−0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $0.0 B. The operating margin ran −14.3% in the latest quarter. — as of 5 August 2026.
What is RE/MAX Holdings, Inc.'s market cap?
RE/MAX Holdings, Inc.'s market capitalisation is $0.0 B at a stock price of $9.7. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is RE/MAX Holdings, Inc.'s P/E ratio?
RE/MAX Holdings, Inc. trades at a P/E of 885.9×, at the 70th percentile of its own 4-year range, against a long-run median of 36.5×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does RE/MAX Holdings, Inc. pay a dividend?
Yes — RE/MAX Holdings, Inc. declared $0.23 per share for Sep 23 (2 quarters on file, too few for a trailing-twelve-month total). — as of 5 August 2026.
What is RE/MAX Holdings, Inc.'s dividend per share?
RE/MAX Holdings, Inc.'s most recently declared dividend is $0.23 per share for Sep 23. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
Is RE/MAX Holdings, Inc. overvalued?
On its own history, RE/MAX Holdings, Inc. looks expensive against its own history: its P/E of 885.9× sits at the 70th percentile of its 4-year range (long-run median 36.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 5 August 2026.
How is RE/MAX Holdings, Inc. performing?
RE/MAX Holdings, Inc. is topping out, 16 weeks in. Against the S&P 500 it has been behind on a trailing-13-week view for 2 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
Is RE/MAX Holdings, Inc. in an uptrend?
It is stalling — the price is topping out (week 16 of stage 3), trading +18.6% versus its 200-day average and at 74% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is RE/MAX Holdings, Inc. beating the market?
Not lately — on a trailing-13-week view RE/MAX Holdings, Inc. is currently behind the S&P 500 (2 weeks and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved −76% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.
Will RE/MAX Holdings, Inc.'s stock price go up?
This page publishes no price forecast for RE/MAX Holdings, Inc. What it measures instead: the stock price is $9.7, the price is topping out 16 weeks in. Its P/E of 885.9× sits at the 70th percentile of its own 4-year range. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against RE/MAX Holdings, Inc.?
Somewhat — short interest is 7.0% of RE/MAX Holdings, Inc.'s tradable float, about 3.6 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
What is RE/MAX Holdings, Inc.'s capex?
RE/MAX Holdings, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 5 August 2026.
What is RE/MAX Holdings, Inc.'s cash flow?
RE/MAX Holdings, Inc. generated $0.0 B of operating cash flow in FY25 and $0.0 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $0.0 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is RE/MAX Holdings, Inc.'s profit real cash?
Yes — over the last 3 fiscal years, 567% of RE/MAX Holdings, Inc.'s reported profit arrived as operating cash. In FY25, operating cash was $0.0 B against reported profit of $0.0 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is RE/MAX Holdings, Inc.?
On the balance sheet, the Z-score reads 0.75 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.
Where is RE/MAX Holdings, Inc. in its business cycle?
RE/MAX Holdings, Inc.'s FY25 operating margin was 17.2%, against a 5-year band of −3.0%–17.2%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran −14.3%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the RE/MAX Holdings, Inc. story?
Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is RE/MAX Holdings, Inc. a stock worth studying right now?
This is not investment advice. The machine read: RE/MAX Holdings, Inc.'s balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup. The sharpest open question: whether the business can earn its way back to positive equity before dilution or restructuring gets there first. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.